Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy.


Journal

Pediatric dermatology
ISSN: 1525-1470
Titre abrégé: Pediatr Dermatol
Pays: United States
ID NLM: 8406799

Informations de publication

Date de publication:
May 2021
Historique:
pubmed: 21 3 2021
medline: 8 7 2021
entrez: 20 3 2021
Statut: ppublish

Résumé

Primary cutaneous anaplastic large cell lymphoma (PC-ALCL) is a CD30+ lymphoproliferative disorder that rarely occurs in children. Although there are currently no consensus guidelines for the treatment of cutaneous lymphoma in the pediatric population, the isolated form of PC-ALCL is typically managed by surgical excision or external beam radiation therapy. We report the case of a 6-year-old girl with primary cutaneous anaplastic large cell lymphoma that was treated with brachytherapy with no recurrence after 21 months of follow-up, suggesting that brachytherapy may be considered as a treatment for pediatric cutaneous large cell anaplastic lymphoma.

Identifiants

pubmed: 33742487
doi: 10.1111/pde.14585
doi:

Substances chimiques

Ki-1 Antigen 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

712-713

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Goddard AL, Vleugels RA, LeBoeuf NR, et al. Palliative therapy for recalcitrant cutaneous T-cell lymphoma of the hands and feet with low-dose, high dose-rate brachytherapy. JAMA Dermatol. 2015;151(12):1354. https://doi.org/10.1001/jamadermatol.2015.3028
Kumar S, Pittaluga S, Raffeld M, Guerrera M, Seibel NL, Jaffe ES. Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature. Pediatr Dev Pathol. 2005;8(1):52-60. https://doi.org/10.1007/s10024-004-8087-6
Oschlies I, Lisfeld J, Lamant L, et al. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study. Haematologica. 2013;98(1):50-56. https://doi.org/10.3324/haematol.2012.065664
Vergier B, Beylot-Barry M, Pulford K, et al. statistical evaluation of diagnostic and prognostic features of cd30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases. Am J Surg Pathol. 1998;22(10):1192-1202.
Otter SJ, Stewart AJ, Devlin PM. Modern brachytherapy. Hematol Oncol Clin North Am. 2019;33(6):1011-1025. https://doi.org/10.1016/j.hoc.2019.08.011

Auteurs

Danny W Linggonegoro (DW)

Dermatology Program, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Lindsay McCormack (L)

Dermatology Program, Boston Children's Hospital, Boston, MA, USA.
University of Massachusetts Medical School, Worcester, MA, USA.

Pierre-Olivier Grenier (PO)

Dermatology Program, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Lynda M Vrooman (LM)

Harvard Medical School, Boston, MA, USA.
Dana-Farber Cancer Institute, Boston, MA, USA.

Phillip M Devlin (PM)

Harvard Medical School, Boston, MA, USA.
Division of Brachytherapy, Department of Radiation Oncology, Dana Farber Brigham and Women's Cancer Center, Boston, MA, USA.

Jennifer T Huang (JT)

Dermatology Program, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH